Skip to main content
NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.40%AAPL+2.07%GOOGL+0.03%MSFT-0.04%AMZN+0.20%TSM-0.79%SPCX+2.01%AVGO+0.19%META+0.24%TSLA-0.36%SKHY-3.59%MU-3.98%BRK-B-0.16%LLY+0.62%JPM-0.48%AMD-2.20%WMT+0.12%V-0.23%XOM-0.14%ASMLa-1.48%JNJ-0.16%INTC-3.83%MA-0.51%0700.HK-1.94%ORCL-1.80%1398.HK+0.79%BAC-0.50%ABBV+0.44%CSCO-0.50%CVX-0.61%COST-0.10%LRCX-3.48%KO+0.82%CAT-0.87%AMAT-2.00%0005.HK-0.78%AP2d-1.26%UNH-0.75%DELL-2.68%HSBA.L-1.05%MS-0.15%PG-0.26%GE+0.09%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.20%HD-0.98%GS-0.32%0939.HK+1.66%NZDJPY-2.69%AUDJPY-1.94%CHFJPY-1.66%USDJPY-1.50%GBPJPY-1.39%EURNZD+1.38%EURJPY-1.36%CADJPY-1.36%NZDCAD-1.35%GBPNZD+1.31%NZDUSD-1.23%NZDCHF-1.06%USDNOK+0.94%EURNOK+0.90%CHFNOK+0.82%AUDNZD+0.78%NOKJPY-0.70%USDZAR+0.69%USDSEK+0.67%EURZAR+0.65%EURSEK+0.63%AUDDKK-0.62%AUDCAD-0.61%EURAUD+0.59%GBPZAR+0.55%CHFSEK+0.55%GBPAUD+0.53%AUDSGD-0.50%AUDUSD-0.45%USDMXN+0.43%GBPTRY+0.41%USDTHB+0.41%NZDSGD-0.34%GBPHKD+0.32%EURCHF+0.29%AUDNOK+0.29%GBPMXN-0.28%CADCHF+0.28%AUDCHF-0.28%GBPCHF+0.25%USDPLN+0.23%EURPLN+0.19%USDCHF+0.17%USDILS+0.16%USDSGD+0.15%EURUSD+0.13%USDCAD-0.12%EURSGD+0.12%USDTRY+0.11%GBPUSD+0.10%EURCZK-0.10%NZDMXN-0.09%SGDJPY+0.08%USDCNH+0.05%EURGBP+0.05%EURHKD-0.05%GBPCAD-0.05%USDCOP-0.04%EURCNH+0.04%CHFSGD+0.04%USDDKK+0.03%GBPSGD+0.02%PLNJPY+0.01%USDHKD+0.01%EURDKK0.00%EURCAD0.00%XPTUSD-4.76%HG1-4.48%GAGUSD-4.14%XAGUSD-4.14%UKOIL+3.50%USOIL+3.10%SUGAR+1.64%GAUUSD-0.92%XAUUSD-0.92%COTTON+0.71%S1+0.63%COFFEE-0.56%BTCUSD-1.22%ETHUSD-1.04%USDTUSD-0.02%XRPUSD-2.61%SOLUSD-1.44%TRXUSDT0.00%ZECUSDT-5.72%DOGEUSD-2.86%XMRUSDT-1.69%LINKUSD-1.08%XLMUSD-1.94%BCHUSDT-10.58%LTCUSD-1.72%UNIUSD-3.41%TONUSD+24.88%HBARUSDT-1.87%SUIUSD-3.40%TAOUSDT-5.14%AAVEUSD-2.85%DOTUSDT-3.61%ICPUSDT-0.90%ONDOUSDT-2.84%WLDUSDT-2.67%ATOMUSDT-3.41%ARBUSDT+1.37%JUPUSDT-2.96%INJUSDT-4.87%STXUSDT-3.07%FETUSDT-3.62%TIAUSDT-0.87%PYTHUSDT-0.07%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-2.94%WIFUSDT-4.89%OPUSDT-3.00%IOTAUSDT-3.86%POLUSDT-5.76%AXSUSDT-2.47%FARTCOINUSDT-2.74%EOSUSDT-0.68%DYDXUSDT-0.71%ORDIUSDT-0.85%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
CR

Charles River Laboratories International, Inc. (CRL)

NYSE • Healthcare

$278.35
-$2.4 (-0.9%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$278.54
Previous Close$278.35
Day Range$275 - $280.75
Avg. Volume (3M)861.5K
Market Cap$13.4B
52 Week Range
$144.26$303.31
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1B100%
Gross Profitminus cost of goods$363.3M36%
Operating Incomeminus R&D and overhead$119.8M12%

Fundamentals & Financials

Revenue (TTM)
$3.9B
Net Income (TTM)
-$238.4M
EPS (TTM)
-$4.84
ROA (TTM)
-3.17%
Current Ratio
1.35
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.6%Q1 2026$2.39
+5.1%Q2 2026$2.06
+10.2%Q3 2026$3.02
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +10.2%

Charles River Laboratories International beat expectations on both the top and bottom line in the second fiscal quarter of 2026, based on preliminary results reported Aug. 5. Revenue fell 3% to about $1.0 billion from $1.03 billion a year ago, but still came in above the $977.2 million estimate by 2.8%, while adjusted EPS of $3.02 topped the $2.77 consensus by 9% and was down 3% from $3.12 a year earlier. Operating income of about $119.9 million left operating margin near 12%, and operating cash flow was $179.7 million as the company repurchased about $115.6 million of stock. Consensus for the next period calls for EPS of $3.05 on revenue of $941.8 million.

View full earnings history

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. is a healthcare research-services company listed on the NYSE under CRL that supports pharmaceutical and biotechnology customers across preclinical drug development, laboratory testing, and research model supply. Its operations produced $4.0 billion of revenue in FY2025.

Name
Charles River Laboratories International, Inc.
CEO
Birgit Girshick
Website
www.criver.com
Industry
Healthcare
Year Founded
1947
Employees
19,000

Today's Snapshot

AI-generated

The session opened with CRL 1.1% lower at 275.38, while its sector was flat.

Trading Volume

Below 10d avg (693.4K)

71.9K

vs S&P 500 Today

Underperforming Market

-1.29%

Updated: September 10, 2026 at 14:53 UTC

CRL Headlines

Citi Resets Life Sciences And MedTech Views

March 11, 2026

5 min read
View All News

Technical Indicators

4 Buy2 Neutral2 Sell
CRL is trading near 273.38 with mixed short-term weakness but clear longer-term strength: the 10–20 period averages sit above the current price while the 50/100/200-day averages remain comfortably below, suggesting the broader trend is still bullish. Momentum is subdued with RSI near neutral and MACD holding, yet ADX registers a strong-trend reading and ATR shows moderate volatility; volume readings are conflicting. Pivot resistance lies above current levels. Technical takeaway: buy stance reflects dominant longer-term moving averages despite short-term consolidation and mixed momentum.
All signals
  • EMA (5 indicators)$212.07 - $283.93
    Buy
  • RSI (14)47.26
    Neutral
  • Stochastic %K (14, 3, 3)6.04
    Buy
  • MACD Level (12, 26)6.73
    Neutral

Peers & Related Assets

RVTYRevvity, Inc.
$123.85-2.5%
BAXBaxter International Inc.
$24.39-1.9%
PENPenumbra, Inc.
$319.57+0.1%
DVADaVita Inc.
$181.3-0.9%
BIOBio-Rad Laboratories, Inc.
$376.97-0.8%
AVTRAvantor, Inc.
$14.88-2.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.